Globus Medical (GMED) Tops Q1 EPS by 5c; Raises Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Globus Medical Reports First Quarter 2018 Results
May 2, 2018 4:15 PM EDTAUDUBON, Pa., May 02, 2018 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the first quarter ended March 31, 2018.
Worldwide sales were $174.4 million, an increase of 11.9% as reported, or 10.8% in constant currencyFirst quarter net income was $39.5 million, or 22.7% of salesDiluted earnings per share (EPS) were $0.39Non-GAAP diluted EPS were $0.41Non-GAAP adjusted EBITDA was 35.4% of salesWe had a strong first quarter with worldwide sales up 11.9% over the first quarter of 2017 at $174... More
